Loading...

Tilray Brands, Inc.

TLRYNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$6.75
$-0.19(-2.74%)
U.S. Market opens in NaNh NaNm

Tilray Brands, Inc. (TLRY) Stock Overview

Explore Tilray Brands, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap786.7M
P/E Ratio-0.41
EPS (TTM)$-14.63
ROE-0.93%
Fundamental Analysis

AI Price Forecasts

1 Month$6.81
3 Months$11.67
1 Year Target$10.82

TLRY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Tilray Brands, Inc. (TLRY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.23, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.82.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.41 and a market capitalization of 786.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.74%
5-Day Change
-3.16%
1-Month Change
1.35%
3-Month Change
-25.41%
6-Month Change
-54.70%
Year-to-Date (YTD) Change
-25.25%
1-Year Change
37.20%
3-Year Change
-71.28%
5-Year Change
-96.22%
All-Time (Max) Change
-96.99%

Contact Information

12064329325
265 Talbot Street West, Leamington, ON, N8H 5L4

Company Facts

2,650 Employees
IPO DateJul 19, 2018
CountryCA
Actively Trading

Frequently Asked Questions